title: [Cysteine proteinases and their inhibitors in the development of mouse HA-1 hepatoma and antineoplastic therapy].
abstract: Development of murine HA-1 hepatoma was accompanied by increased activity of cathepsin B (in ascitic cells), cathepsin D (in ascitic fluid) and increased activity of procathepsin B. There were some changes of cysteine proteinases in liver and spleen, not involved directly into tumor growth. The most prominent changes included the decreased level of cysteine proteinase inhibitors cystatin C and stefin A in ascitic cells (and to a lesser degree in liver tissue). During tumor development serum cystatin C concentration decreased by 3-times compared to intact mice. Treatment by antitumor drug Ukraine increased life span of mice with HA-1 hepatoma (transplanted intravenously), decreased the increment of tumor weight. In ascite such treatment caused a decrease of number of tumor cells and an increase of number of macrophages. Ukraie (administered once or 5-times in a dose of 0.5 mg per mice) increased cystatin C level, revealing protective mechanism of action.
authors.affiliation: Institute of Physiology RAMS, Institute of Biochemistry RAMS, Novosibirsk.
authors.forename: O N
authors.initials: ON
authors.lastname: Poteriaeva
authors.forename: T A
authors.initials: TA
authors.lastname: Korolenko
authors.forename: I G
authors.initials: IG
authors.lastname: Svechnikova
authors.forename: S Ia
authors.initials: SIa
authors.lastname: Zhanaeva
authors.forename: O V
authors.initials: OV
authors.lastname: Falameeva
authors.forename: V I
authors.initials: VI
authors.lastname: Kaledin
authors.forename: J W
authors.initials: JW
authors.lastname: Nowicky
mesh_terms: D000470:Alkaloids / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001201:Ascites / Q000201:enzymology / Q000378:metabolism / Q000473:pathology; D001600:Berberine Alkaloids; D002401:Cathepsin B / Q000378:metabolism; D002402:Cathepsin D / Q000378:metabolism; D056668:Cathepsin L; D002403:Cathepsins / Q000378:metabolism; D055312:Cystatin A; D055316:Cystatin C; D015891:Cystatins / Q000378:metabolism; D003546:Cysteine Endopeptidases / Q000378:metabolism*; D015853:Cysteine Proteinase Inhibitors / Q000378:metabolism*; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism; D008297:Male; D051379:Mice; D009368:Neoplasm Transplantation; D010617:Phenanthridines
chemical_list: D000470:Alkaloids; D000970:Antineoplastic Agents; D001600:Berberine Alkaloids; C525031:Cst3 protein, mouse; C501463:Csta1 protein, mouse; D055312:Cystatin A; D055316:Cystatin C; D015891:Cystatins; D015853:Cysteine Proteinase Inhibitors; D010617:Phenanthridines; C060921:ukrain; D002403:Cathepsins; D003546:Cysteine Endopeptidases; D002401:Cathepsin B; D056668:Cathepsin L; C534278:Ctsl protein, mouse; D002402:Cathepsin D